Osteoclast lineage and function.

Osteoclasts are members of the monocyte/macrophage lineage and are formed by cellular fusions from their mononuclear precursors. Their differentiation is regulated by a number of other cells and their products, especially by RANKL and M-CSF. The resorbing osteoclasts are polarized and show specific plasma membrane domains. Polarization and bone resorption need a continuous membrane trafficking and modulation of the cytoskeleton. The most characteristic feature of osteoclasts is their unique capacity to dissolve crystalline hydroxyapatite by targeted secretion of HCl into the extracellular resorption lacuna. Organic matrix is degraded by enzymes like cathepsin K and the degradation products are transcytosed through the cell for secretion. Dissolution of hydroxyapatite releases large amounts of soluble calcium, phosphate and bicarbonate. Removal of these ions apparently involves the vesicular pathways and direct ion transport via different ion exchangers, channels and pumps. Detailed molecular knowledge of osteoclast differentiation and function has helped us to identify several target molecules and develop specific treatments to inhibit pathological bone resorption in various skeletal diseases.

[1]  T. Iwamoto,et al.  Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption. , 2007, Endocrinology.

[2]  H. Väänänen,et al.  Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. , 1997, Journal of cell science.

[3]  J. Tuukkanen,et al.  Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts , 1990, The Journal of cell biology.

[4]  W. Boron,et al.  Colony-stimulating factor-1 increases osteoclast intracellular pH and promotes survival via the electroneutral Na/HCO3 cotransporter NBCn1. , 2007, Endocrinology.

[5]  B. Gelb,et al.  Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency , 1996, Science.

[6]  P. Lehenkari,et al.  Removal of osteoclast bone resorption products by transcytosis. , 1997, Science.

[7]  T. Martin,et al.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Hentunen,et al.  Characterization of Circulating Human Osteoclast Progenitors: Development of In Vitro Resorption Assay , 2005, Calcified Tissue International.

[9]  O. Jaillon,et al.  The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. , 2000, Bone.

[10]  D. Wang,et al.  Identification of the type II Na(+)-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice. , 2001, Bone.

[11]  K. Miyamoto,et al.  Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells. , 2007, American journal of physiology. Cell physiology.

[12]  B. Troen The Regulation of Cathepsin K Gene Expression , 2006, Annals of the New York Academy of Sciences.

[13]  H. Väänänen,et al.  Osteoclast Ruffled Border Has Distinct Subdomains for Secretion and Degraded Matrix Uptake , 2003, Traffic.

[14]  T. Jentsch,et al.  ClC-7 requires Ostm1 as a β-subunit to support bone resorption and lysosomal function , 2006, Nature.

[15]  Seoung-Hoon Lee,et al.  NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). , 2008, Molecular endocrinology.

[16]  H. Väänänen,et al.  Pharmacological Sequestration of Intracellular Cholesterol in Late Endosomes Disrupts Ruffled Border Formation in Osteoclasts , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  L. Addadi,et al.  The molecular dynamics of osteoclast adhesions. , 2006, European journal of cell biology.

[18]  D. Mcnulty,et al.  Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.

[19]  P. Schlesinger,et al.  Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. , 1989, The Journal of clinical investigation.

[20]  L. Notarangelo,et al.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis , 2000, Nature Genetics.

[21]  D. Barisani,et al.  CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts. , 2007, Experimental hematology.

[22]  E H Burger,et al.  In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes , 1982, The Journal of experimental medicine.

[23]  C. Czupalla,et al.  Proteomic Analysis of Lysosomal Acid Hydrolases Secreted by Osteoclasts , 2006, Molecular & Cellular Proteomics.

[24]  P. Bekker,et al.  Biochemical characterization of an electrogenic vacuolar proton pump in purified chicken osteoclast plasma membrane vesicles , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Veber,et al.  Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  K. Miyamoto,et al.  Characterization of inorganic phosphate transport in osteoclast-like cells. , 2005, American journal of physiology. Cell physiology.

[28]  K. Väänänen,et al.  Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. , 1990, Biochemical and biophysical research communications.

[29]  M. Polymeropoulos,et al.  A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. , 1996, Genome research.

[30]  K. Ohya,et al.  Expression of MT1-MMP during deciduous tooth resorption in odontoclasts , 2006, Journal of Bone and Mineral Metabolism.

[31]  J. Risteli,et al.  Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts , 2001 .

[32]  R. Kiviranta,et al.  Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. , 2007, Bone.

[33]  C. Peters,et al.  Osteoclastic Bone Degradation and the Role of Different Cysteine Proteinases and Matrix Metalloproteinases: Differences Between Calvaria and Long Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  J. Delaissé,et al.  A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.

[35]  Yongwon Choi,et al.  v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation , 2006, Nature Medicine.

[36]  K. Metsikkö,et al.  The architecture of microtubular network and Golgi orientation in osteoclasts--major differences between avian and mammalian species. , 2003, Experimental cell research.

[37]  C. Supuran,et al.  Membrane-bound carbonic anhydrases in osteoclasts. , 2007, Bone.

[38]  E. Génot,et al.  CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. , 2007, Molecular biology of the cell.

[39]  K. Väänänen,et al.  Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics. , 2005, Advanced drug delivery reviews.

[40]  Yi Sun,et al.  Possible Role of Direct Rac1-Rab7 Interaction in Ruffled Border Formation of Osteoclasts* , 2005, Journal of Biological Chemistry.

[41]  K. Väänänen,et al.  Organization of osteoclast microfilaments during the attachment to bone surface in vitro , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  Yucheng Wang,et al.  Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. , 2007, Human molecular genetics.

[43]  I. Kola,et al.  Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  K. Hultenby,et al.  Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. , 2002, Experimental cell research.

[45]  S. Teitelbaum,et al.  Osteoclastic bone resorption by a polarized vacuolar proton pump. , 1989, Science.

[46]  E. Vuorio,et al.  Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. , 2005, Bone.

[47]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[48]  M. Leppilampi,et al.  Carbonic anhydrase isoenzymes in isolated rat peripheral monocytes, tissue macrophages, and osteoclasts. , 1987, Bone.

[49]  A. Schulz,et al.  Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man , 2001, Cell.

[50]  A. Uitterlinden,et al.  The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Claus Christiansen,et al.  Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity? , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  Yingwei Hu,et al.  Inhibition of the osteoclast V‐ATPase by small interfering RNAs , 2005, FEBS letters.

[53]  P. Vihko,et al.  Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  Lynda F. Bonewald,et al.  Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.

[55]  R. Luben,et al.  Effects of parathormone and calcitonin on citrate and hyaluronate metabolism in cultured bone. , 1976, Endocrinology.

[56]  Nathan Nelson,et al.  The emerging structure of vacuolar ATPases. , 2006, Physiology.

[57]  D. Reid,et al.  Polymorphisms of the CLCN7 Gene Are Associated With BMD in Women , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  K. Sundquist Characterization of ATP-dependent proton transport in medullary bone-derived microsomes. , 1993, Bone and mineral.

[59]  K. Hultenby,et al.  Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts* , 2005, Journal of Biological Chemistry.

[60]  R. Edwards,et al.  Secretion of L‐glutamate from osteoclasts through transcytosis , 2006, The EMBO journal.

[61]  C. W. Prince,et al.  Roles of hyaluronan in bone resorption , 2004, BMC musculoskeletal disorders.

[62]  T. Chambers,et al.  Regulation and enzymatic basis of bone resorption by human osteoclasts. , 2007, Clinical science.

[63]  H. Väänänen,et al.  Potential Function for the ROS‐Generating Activity of TRACP , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  B. Samuelsson,et al.  Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. , 2008, Bone.

[65]  Hiroaki Nakamura,et al.  Transcytosis of calcium from bone by osteoclast-like cells evidenced by direct visualization of calcium in cells. , 2005, Archives of Biochemistry and Biophysics.

[66]  Z. Werb,et al.  Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration , 2007, PloS one.

[67]  H. Väänänen,et al.  Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. , 1994, The Journal of clinical investigation.

[68]  V. Parikka,et al.  Downregulation of Small GTPase Rab7 Impairs Osteoclast Polarization and Bone Resorption* 210 , 2001, The Journal of Biological Chemistry.

[69]  J. Tuukkanen,et al.  Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro , 1986, Calcified Tissue International.

[70]  K. Väänänen,et al.  Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[71]  A. Ramírez,et al.  Identification of a novel mutation in the coding region of the grey‐lethal gene OSTM1 in human malignant infantile osteopetrosis , 2004, Human mutation.

[72]  A. Schulz,et al.  Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. , 2000, Human molecular genetics.

[73]  M. Karsdal,et al.  The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. , 2005, Drug news & perspectives.

[74]  L. Addadi,et al.  The Architecture of the Adhesive Apparatus of Cultured Osteoclasts: From Podosome Formation to Sealing Zone Assembly , 2007, PloS one.

[75]  T. Cox,et al.  Tartrate‐Resistant Acid Phosphatase Knockout Mice , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  Paivi,et al.  Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3',5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[77]  M. Eiden,et al.  Na+-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions. , 2003, American journal of physiology. Cell physiology.

[78]  Yuqiong Liang,et al.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification , 1999, Nature Genetics.

[79]  R. Baron,et al.  Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border , 1985, The Journal of cell biology.

[80]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[81]  A. Rinne,et al.  Cystatin B as an intracellular modulator of bone resorption. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[82]  P. Schlesinger,et al.  Purification of a stilbene sensitive chloride channel and reconstitution of chloride conductivity into phospholipid vesicles. , 1990, Biochemical and biophysical research communications.

[83]  H. Väänänen,et al.  Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. , 2006, Clinical laboratory.